World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
18118
World Ranking
2413
National Ranking
165

Medicine

D-Index
70
Citations
18119
World Ranking
20092
National Ranking
1049

Thomas Blankenstein publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas Blankenstein sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 257 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas Blankenstein D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas Blankenstein sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas Blankenstein is affiliated with the Max Delbrück Center for Molecular Medicine in Germany. Their research spans primarily the fields of Medicine and Immunology and Microbiology, with a strong focus on subfields including Oncology, Immunology, Molecular Biology, Hematology, and Genetics.

The main topics addressed in Blankenstein's work include:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Vaccines and immunoinformatics approaches
  • Virus-based gene therapy research

Among Blankenstein's recent publications are:

  • The role of CD4 T cells in rejection of solid tumors, 2021, Current Opinion in Immunology
  • IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis, 2022, Science Advances
  • CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus, 2021, Cancers
  • IFNγ binding to extracellular matrix prevents fatal systemic toxicity, 2023, Nature Immunology
  • Adjuvant radiotherapy and local recurrence in vulvar cancer - a subset analysis of the AGO-CaRE-1 study, 2021, Gynecologic Oncology

The recurring publication venues for Blankenstein include:

  • Journal for ImmunoTherapy of Cancer
  • Nature Immunology
  • Blood
  • Frontiers in Immunology
  • Geburtshilfe und Frauenheilkunde

Frequent co-authors in Blankenstein's work are:

  • Gerald Willimsky
  • Elisa Kieback
  • Leo Hansmann
  • Vivian Scheuplein
  • Matthias Leisegang

Best Publications

  • CCR7 Governs Skin Dendritic Cell Migration under Inflammatory and Steady-State Conditions

    Lars Ohl;Mariette Mohaupt;Niklas Czeloth;Gabriele Hintzen

  • CD4+ T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells

    Zhihai Qin;Thomas Blankenstein

  • Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

    Gerald Willimsky;Thomas Blankenstein;Thomas Blankenstein

  • B cells inhibit induction of T cell-dependent tumor immunity.

    Zhihai Qin;Günther Richter;Thomas Schüler;Sabrina Ibe

  • The determinants of tumour immunogenicity.

    Thomas Blankenstein;Thomas Blankenstein;Pierre G. Coulie;Eli Gilboa;Elizabeth M. Jaffee

  • Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

    Brocke S;Gijbels K;Allegretta M;Ferber I

  • Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

    Thomas Blankenstein;Zheng Hong Qin;K Uberla;Werner Muller

  • A Critical Requirement of Interferon γ-mediated Angiostasis for Tumor Rejection by CD8+ T Cells

    Zhihai Qin;Johannes Schwartzkopff;Felicia Pradera;Thomas Kammertoens

  • Interleukin 7 induces CD4+ T cell-dependent tumor rejection.

    H Hock;M Dorsch;T Diamantstein;T Blankenstein

  • CD4-Positive T Lymphocytes Provide a Neuroimmunological Link in the Control of Adult Hippocampal Neurogenesis

    Susanne A. Wolf;Susanne A. Wolf;Susanne A. Wolf;Barbara Steiner;Barbara Steiner;Akgul Akpinarli;Thomas Kammertoens;Thomas Kammertoens

  • Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

    Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Zhihai Qin

  • Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

    Barbara Seliger;Ursula Wollscheid;Frank Momburg;Thomas Blankenstein

  • Retroviral Vectors for High-Level Transgene Expression in T Lymphocytes

    Boris Engels;Hakan Cam;Thomas Schüler;Stefano Indraccolo

  • Tumour ischaemia by interferon-γ resembles physiological blood vessel regression

    Thomas Kammertoens;Christian Friese;Christian Friese;Ainhoa Arina;Christian Idel

  • Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells.

    Z Qin;G Noffz;M Mohaupt;T Blankenstein

  • Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

    Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  • The role of tumor stroma in the interaction between tumor and immune system.

    Thomas Blankenstein

  • Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

    Anna Kruschinski;Andreas Moosmann;Isabel Poschke;Håkan Norell

  • Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.

    Natacha Bessis;Marie-Christophe Boissier;Pascual Ferrara;Thomas Blankenstein

  • T Helper Cell Type 1–associated and Cytotoxic T Lymphocyte–mediated Tumor Immunity Is Impaired in Interleukin 4–deficient Mice

    Thomas Schüler;Zhihai Qin;Sabrina Ibe;Nancy Noben-Trauth

Frequent Co-Authors

Zhihai Qin
Zhihai Qin Chinese Academy of Sciences
Wolfgang Uckert
Wolfgang Uckert Max Delbrück Center for Molecular Medicine
Tibor Diamantstein
Tibor Diamantstein Freie Universität Berlin
Bernd Dörken
Bernd Dörken Charité - University Medicine Berlin
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin
Bernd Dörken
Bernd Dörken Charité - University Medicine Berlin
Peter T. Daniel
Peter T. Daniel Max Delbrück Center for Molecular Medicine
Rolf Kiessling
Rolf Kiessling Karolinska Institute
Werner Müller
Werner Müller University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which can be pursued through specialized online programs. For those interested in advancing their nursing skills quickly, an accelerated nurse practitioner program offers a fast track to clinical expertise and leadership roles.

If you're coming from a non-nursing background, online ADN programs for non nurses provide a convenient way to enter the nursing profession while building foundational skills relevant to immunology and patient care.

For students seeking an efficient path to become registered nurses, some of the easiest ABSN to get into can offer flexible entry points, making it easier to start a nursing career with a focus on immunological health.

Additionally, pursuing accredited LPN programs that are easy to get into can provide a solid healthcare foundation, allowing for hands-on patient experience and eventual pathway advancements in immunology-related fields.

Best Scientists Citing Thomas Blankenstein

Trending Scientists

Recently Published Articles